Follow
Roberto Salgado
Roberto Salgado
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, ...
Annals of oncology 26 (2), 259-271, 2015
25842015
Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition …
S Loi, N Sirtaine, F Piette, R Salgado, G Viale, F Van Eenoo, G Rouas, ...
J Clin Oncol 31 (7), 860-867, 2013
17232013
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
S Loi, S Michiels, R Salgado, N Sirtaine, V Jose, D Fumagalli, ...
Annals of oncology 25 (8), 1544-1550, 2014
13302014
CD4+ follicular helper T cell infiltration predicts breast cancer survival
C Gu-Trantien, S Loi, S Garaud, C Equeter, M Libin, A De Wind, M Ravoet, ...
The Journal of clinical investigation 123 (7), 2873-2892, 2013
9882013
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
S Turajlic, K Litchfield, H Xu, R Rosenthal, N McGranahan, JL Reading, ...
The lancet oncology 18 (8), 1009-1021, 2017
8372017
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
P Savas, R Salgado, C Denkert, C Sotiriou, PK Darcy, MJ Smyth, S Loi
Nature reviews Clinical oncology 13 (4), 228-241, 2016
8002016
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
P Savas, B Virassamy, C Ye, A Salim, CP Mintoff, F Caramia, R Salgado, ...
Nature medicine 24 (7), 986-993, 2018
7932018
Neoantigen-directed immune escape in lung cancer evolution
R Rosenthal, EL Cadieux, R Salgado, MA Bakir, DA Moore, CT Hiley, ...
Nature 567 (7749), 479-485, 2019
7032019
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
L Voorwerk, M Slagter, HM Horlings, K Sikorska, KK van de Vijver, ...
Nature medicine 25 (6), 920-928, 2019
6772019
Assessing tumor infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (6), 311, 2017
6532017
Tumor-infiltrating lymphocytes and prognosis: a pooled individual patient analysis of early-stage triple-negative breast cancers
S Loi, D Drubay, S Adams, G Pruneri, PA Francis, M Lacroix-Triki, ...
Journal of clinical oncology 37 (7), 559, 2019
6432019
Assessing tumor infiltrating lymphocytes in solid tumors: A practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (5), 235, 2017
5882017
Tumor-infiltrating lymphocytes and associations with pathological complete response and event-free survival in HER2-positive early-stage breast cancer treated with lapatinib …
R Salgado, C Denkert, C Campbell, P Savas, P Nuciforo, C Aura, ...
JAMA oncology 1 (4), 448-455, 2015
5842015
Circulating interleukin‐6 predicts survival in patients with metastatic breast cancer
R Salgado, S Junius, I Benoy, P Van Dam, P Vermeulen, E Van Marck, ...
International journal of cancer 103 (5), 642-646, 2003
5822003
The 2019 WHO classification of tumours of the breast
PH Tan, I Ellis, K Allison, E Brogi, SB Fox, S Lakhani, AJ Lazar, EA Morris, ...
Histopathology, 2020
5362020
RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1/PD-L1 immune …
S Loi, S Dushyanthen, PA Beavis, R Salgado, C Denkert, P Savas, ...
Clinical Cancer Research 22 (6), 1499-1509, 2016
5242016
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
DB Johnson, MV Estrada, R Salgado, V Sanchez, DB Doxie, SR Opalenik, ...
Nature communications 7 (1), 10582, 2016
4922016
Assessment of Ki67 in breast cancer: updated recommendations from the international Ki67 in breast cancer working group
TO Nielsen, SCY Leung, DL Rimm, A Dodson, B Acs, S Badve, C Denkert, ...
JNCI: Journal of the National Cancer Institute 113 (7), 808-819, 2021
4202021
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in …
MV Dieci, N Radosevic-Robin, S Fineberg, G Van den Eynden, N Ternes, ...
Seminars in cancer biology 52, 16-25, 2018
400*2018
Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival
IH Benoy, R Salgado, P Van Dam, K Geboers, E Van Marck, S Scharpé, ...
Clinical Cancer Research 10 (21), 7157-7162, 2004
4002004
The system can't perform the operation now. Try again later.
Articles 1–20